Jasper Therapeutics Valuation
| JSPRW Stock | USD 0.20 0.01 5.26% |
Jasper Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model calculates the value of Jasper Therapeutics from evaluating the firm fundamentals such as Net Income of (64.47 M), return on equity of -0.71, and Return On Asset of -0.41 as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Jasper Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Jasper Therapeutics is based on 3 months time horizon. Increasing Jasper Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Jasper stock is determined by what a typical buyer is willing to pay for full or partial control of Jasper Therapeutics. Since Jasper Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Jasper Stock. However, Jasper Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.2 | Real 0.13 | Hype 0.2 | Naive 0.2 |
The intrinsic value of Jasper Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Jasper Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Jasper Therapeutics helps investors to forecast how Jasper stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jasper Therapeutics more accurately as focusing exclusively on Jasper Therapeutics' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Jasper Therapeutics' intrinsic value based on its ongoing forecasts of Jasper Therapeutics' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Jasper Therapeutics' closest peers.
Jasper Therapeutics Cash |
|
Jasper Valuation Trend
Analysing the historical paterns of Jasper Therapeutics' enterprise value and its market capitalization is a good way to estimate and gauge the value of Jasper Therapeutics over time and is usually enough for investors to make rational market timing decisions.
Jasper Therapeutics Total Value Analysis
Jasper Therapeutics is currently projected to have takeover price of 0 with market capitalization of 0, debt of 2.79 M, and cash on hands of 16.76 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Jasper Therapeutics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
0 | 0 | 2.79 M | 16.76 M |
Jasper Therapeutics Asset Utilization
One of the ways to look at asset utilization of Jasper is to check how much profit was generated for every dollar of assets it reports. Jasper Therapeutics retains a negative application of resources of -0.41 (percent), losing $0.004092 for each dollar of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Jasper Therapeutics shows how discouraging it operates for each dollar spent on its resources.Jasper Therapeutics Profitability Analysis
Net Loss for the year was (64.47 M) with profit before overhead, payroll, taxes, and interest of 0.About Jasper Therapeutics Valuation
Our relative valuation model uses a comparative analysis of Jasper Therapeutics. We calculate exposure to Jasper Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Jasper Therapeutics's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -1.1 M | -1.2 M |
Jasper Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Jasper Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 10.4 M |
Jasper Therapeutics Current Valuation Indicators
Valuation refers to the process of determining the present value of Jasper Therapeutics and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Jasper we look at many different elements of the entity such as Jasper's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Jasper Therapeutics, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Jasper Therapeutics' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Jasper Therapeutics' worth.Additional Tools for Jasper Stock Analysis
When running Jasper Therapeutics' price analysis, check to measure Jasper Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jasper Therapeutics is operating at the current time. Most of Jasper Therapeutics' value examination focuses on studying past and present price action to predict the probability of Jasper Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jasper Therapeutics' price. Additionally, you may evaluate how the addition of Jasper Therapeutics to your portfolios can decrease your overall portfolio volatility.